Search results
Novartis Patient Information Leaked in Third-Party Data Breach at Lash Group | JD Supra
JD Supra· 26 minutes agoIn this notice, Lash Group explains that the incident resulted in an unauthorized party being able to access sensitive information belonging to patients enrolled in “patient support programs ...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 5 hours agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Cencora data breach exposes US patient info from 8 drug companies
BleepingComputer· 3 hours agoCencora, formerly AmerisourceBergen, is a pharmaceutical services provider specializing in drug...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 57 minutes agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
Latest 340B ruling delivers blow to providers
Healthcare Dive· 2 days agoThe ruling is a win for drug manufacturers, who were previously threatened with fines from the federal government for violating guidance regarding which pharmacies they would send discounted ...
DC Circuit Sides With Manufacturers in '340B' Drug Discount Dispute | National Law Journal
Law.com· 3 days agoJudges Gregory Katsas, J. Michelle Childs and Neomi Rao stated in an opinion that Novartis ...
Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs - Indianapolis...
Indianapolis Business Journal· 4 days agoA Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create ...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 4 hours agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 1 day agoThere's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 1 day agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...